Capha Pharmaceuticals, Inc. engages in the exploration of pharmaceuticals. The company is headquartered in West Kelowna, British Columbia. The company went IPO on 2004-09-20. The firm is engaged in exploring various opportunities in the medical technology space.
根據最新的財務報表(Form-10K),Bombardier Inc. 的總資產為 $13,565,淨isProfitable}為 $899
FPSUF 的關鍵財務比率是什麼?
Bombardier Inc. 的流動比率為 0.93,淨利潤率為 9.41,每股銷售為 $95.04。
Capha Pharmaceuticals Inc 的收入按細分市場或地理位置如何劃分?
Bombardier Inc. 最大收入來源為 Business Aircraft - Manufacturing and Other,在最近的收益報告中收入為 9,014,347,455。就地區而言,United States 是 Bombardier Inc. 的主要市場,收入為 7,625,206,373。